Tag: ML6710i

Age-related Macular Degeneration (AMD)

Application Note / age-related macular degeneration, AMD, application note, ML6710i, ophthalmic treatments, ophthalmology, PDT, Photodynamic therapy

Age-related Macular Degeneration (AMD) Age-related Macular Degeneration (AMD) is a disease causing choroidal neovascularization (CNV) and consequent irreversible damage in the macula. AMD is classified into dry (atrophic) and wet (exudative) forms, with the latter causing faster vision loss and being the leading cause of blindness in people over 65. Introduction to AMD Age-related Macular [...]

Novel ophthalmic laser system paired with focal electroretinography for subthreshold laser therapy of DME

Scientific papers / 689 nm, age-related macular degeneration, AMD, BIOS, clinical trials, DME, fERG, focal electroretinography, fundus imaging, ML6710i, Modulight authors, Modulight Cloud, ophthalmic treatments, retinal diseases, SPIE BIOS 2023, thermal dosimetry

Presented in: SPIE BIOS 2023 Authors: Jukka-Pekka Alanko, Eero Koivumäki, Laura Vesala, Johannes Kivelä, Zoe Ylöniemi, Petteri Uusimaa, Ossi Kaikkonen, Teemu Turunen, Jaakko Nieminen, Jani Tirronen

Novel ophthalmic laser system paired with focal electroretinography for subthreshold laser therapy of DME Read More »

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Scientific papers / age-related macular degeneration, AMD, BIOS, CSC, CSR, drug delivery, ML6710i, Modulight authors, Modulight Cloud, nAMD, oncology, ophthalmology, PCV, PDT, Retina, SLA, slit lamp adapter, SPIE BIOS 2023

Presented in: SPIE BIOS 2023 Authors: Laura Vesala, Eero Koivumäki, Jukka-Pekka Alanko, Timo Tanila, Ivan Baldin, Zoe Ylöniemi, Petteri Uusimaa, Modulight Corp.

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications Read More »

Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release

Scientific papers / AI, BIOS, drug delivery, ICG, liposomes, ML6710i, Modulight authors, Modulight Cloud, ophthalmology, Photonics West

Presented in: SPIE BIOS 2022 Authors: Eero Koivumäki, Laura Vesala, Jukka-Pekka Alanko, Timo Tanila, Petteri Uusimaa, Modulight Corporation (Finland)

Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release Read More »

Protected: Vision-sparing targeted phototherapy for uveal melanoma

Application Note / 689nm, Aura Biosciences, cancer, choroidal melanoma, drug development, drug discovery, medical laser, ML6500, ML6710i, ML7710, MLAKIT, National Cancer Institute, National Institutes of Health, NCI, NIH, ophthalmology, Uveal Melanoma

There is no excerpt because this is a protected post.

Protected: Vision-sparing targeted phototherapy for uveal melanoma Read More »

New Insights on Management of CSCR

Modulight in Media / Bausch + Lomb, CSCR, ML6710i, ML7710, ophthalmology, PDT, Photodynamic therapy, Retina

Retinal Physician – May 1, 2021 Currently, most retina specialists use photodynamic therapy (PDT) with verteporfin (Visudyne; Bausch + Lomb). Photodynamic therapy devices include ML6710i (available for investigational use only in the United States) by Modulight and ML7710 (CE certified; available for investigational use only in the United States) by Modulight.

New Insights on Management of CSCR Read More »

Configurable cloud-connected iPad controlled multimodal ophthalmic laser

Scientific papers / age-related macular degeneration, BIOS, cloud-connected, laser, ML6710i, ophthalmology

Presented in: SPIE BIOS 2021 Authors: Jukka-Pekka Alanko, Visa Kaivosoja, Ivan Baldin, Timo Tanila, Eero Koivumäki, Petteri Uusimaa, Zoe Ylöniemi, Modulight, Inc. (Finland)

Configurable cloud-connected iPad controlled multimodal ophthalmic laser Read More »

Modulight becomes exclusive supplier for BAUSCH + LOMB

Press Releases / 689 nm laser, B+L, medical laser, ML6710i, ophthalmology, PDT, pharmaceutical company, Photodynamic therapy, Visudyne, Visudyne laser

BRIDGEWATER, N.J., December 04, 2018 – Bausch + Lomb, a leading global eye health company, and Modulight, Inc., a designer and manufacturer of lasers and optics for personalized medicine, announced the companies have entered into an exclusive agreement to collaborate and develop a new photodynamic laser specifically designed for use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) therapy.

Modulight becomes exclusive supplier for BAUSCH + LOMB Read More »